ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Most Cited Paper
in Cancer Genomics and Diagnostics
18 Months Post-Publication
Class of 2026
“ctDNA-based molecular residual disease and survival in resectable colorectal cancer”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/cancer-genomics-and-diagnostics/2026/
Topics
Circulating tumor DNA · Minimal residual disease · Colorectal cancer · resectable colorectal cancer · CIRCULATE-Japan GALAXY study · Observational study · adjuvant chemotherapy (ACT) · disease-free survival · Overall survival · Cancer recurrence · ctDNA positivity · ctDNA clearance · ctDNA clearance · ctDNA clearance · ctDNA clearance · post-resection monitoring · stage II colon cancer · stage III colon cancer · stage IV colorectal cancer · MRD window · prognostic biomarker · actionable biomarker subsets · hazard ratio · Risk stratification · adjuvant therapy guidance · Liquid biopsy · Tumor recurrence · mortality risk · ctDNA monitoring · MRD detection
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Cancer Genomics and Diagnostics Papers, Class of 2026. https://pri.pepkio.com/top-papers/cancer-genomics-and-diagnostics/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459